Correlation Between Neuropace and Bruker

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Bruker, you can compare the effects of market volatilities on Neuropace and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Bruker.

Diversification Opportunities for Neuropace and Bruker

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neuropace and Bruker is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of Neuropace i.e., Neuropace and Bruker go up and down completely randomly.

Pair Corralation between Neuropace and Bruker

Given the investment horizon of 90 days Neuropace is expected to generate 2.0 times more return on investment than Bruker. However, Neuropace is 2.0 times more volatile than Bruker. It trades about 0.13 of its potential returns per unit of risk. Bruker is currently generating about -0.06 per unit of risk. If you would invest  739.00  in Neuropace on September 2, 2024 and sell it today you would earn a total of  321.00  from holding Neuropace or generate 43.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Bruker

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Bruker 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bruker has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward-looking signals remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Neuropace and Bruker Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Bruker

The main advantage of trading using opposite Neuropace and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.
The idea behind Neuropace and Bruker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas